Amedisys, Inc.
AMED
Ранг среди акций
#4613
Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of... Amedisys, Inc., along with its various subsidiaries, delivers a spectrum of healthcare solutions throughout the United States. Its operations are structured across four distinct divisions: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment furnishes a diverse array of services provided within individuals' residences. These services support patients in their recovery from surgeries, chronic ailments, or serious illnesses, and also aim to minimize preventable hospital readmissions. This is achieved through its team of proficient nurses, rehabilitation therapists specializing in physical, speech, and occupational therapy, as well as social workers and care assistants who support patients. The Hospice division is dedicated to offering comfort and empathetic support to those facing a terminal illness, encompassing conditions like cancer, heart disease, pulmonary disease, or Alzheimer's. Within the Personal Care segment, patients receive assistance with their routine daily activities. Finally, the High Acuity Care segment extends crucial elements of inpatient hospital care, skilled nursing facility services, and palliative care directly to patients within their own homes. As of December 31, 2021, the company maintained a network comprising 331 home health centers, 175 hospice care centers, 14 personal-care facilities, and 8 high acuity care centers. These facilities are situated across 38 states in the U.S. and the District of Columbia. Amedisys, Inc. was established in 1982 and its principal executive offices are located in Baton Rouge, Louisiana.
Цена акции
$100.99
Последняя синхронизация: 2025-08-15
Рыночная капитализация
$3.31B
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Amedisys, Inc. (AMED)
Категория
Healthcare
Выручка компании Amedisys, Inc. (AMED)
Выручка на Jun 2025 TTM: $2.40B
Согласно последним финансовым отчетам Amedisys, Inc., текущая выручка компании (TTM) составляет $2.40B. В 2023 году компания получила выручку $2.24B больше, чем выручке в 2022 году, которая составила $2.22B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Amedisys, Inc. с 2000 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $2.40B | 2.30% |
| 2024 | $2.35B | 5.01% |
| 2023 | $2.24B | 0.59% |
| 2022 | $2.22B | 0.41% |
| 2021 | $2.21B | 6.88% |
| 2020 | $2.07B | 5.93% |
| 2019 | $1.96B | 17.63% |
| 2018 | $1.66B | 8.40% |
| 2017 | $1.53B | 6.69% |
| 2016 | $1.44B | 12.25% |
| 2015 | $1.28B | 6.31% |
| 2014 | $1.20B | -3.59% |
| 2013 | $1.25B | -16.03% |
| 2012 | $1.49B | 1.19% |
| 2011 | $1.47B | -10.03% |
| 2010 | $1.63B | 7.99% |
| 2009 | $1.51B | 27.46% |
| 2008 | $1.19B | 70.13% |
| 2007 | $697.93M | 28.97% |
| 2006 | $541.15M | 41.83% |
| 2005 | $381.56M | 68.02% |
| 2004 | $227.09M | 59.39% |
| 2003 | $142.47M | 10.08% |
| 2002 | $129.42M | 17.47% |
| 2001 | $110.17M | 21.40% |
| 2000 | $90.76M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| $78.01B | 3,147.34% |
US
|
|
| - | - |
DE
|
|
| $21.81B | 807.94% |
US
|
|
| $3.89B | 62.13% |
SA
|
|
| $11.08B | 361.42% |
BR
|
